ArkAb will be created

The company ArkAb, B Cell Design’s subsidiary, will be created in the coming days. Focused on the in vitro diagnostic market, ArkAb develops, produces and sells monoclonal chimeric antibodies, particularly as a sustainable and reproducible alternative to disease state plasma, used as quality controls in in vitro diagnostic assays.

Go back